User menu

(S)-1-(Pent-4’-enoyl)-4-(hydroxymethyl)-azetidin-2-one derivatives as inhibitors of human fatty acid amide hydrolase (hFAAH): synthesis, biological evaluation and molecular modelling

Bibliographic reference Caruano, Joséphine ; Feledziak, Marion ; Labar, Geoffray ; Michaux, Catherine ; Perpete, Eric ; et. al. (S)-1-(Pent-4’-enoyl)-4-(hydroxymethyl)-azetidin-2-one derivatives as inhibitors of human fatty acid amide hydrolase (hFAAH): synthesis, biological evaluation and molecular modelling. In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 29, no. /, p. 654-662 (2014)
Permanent URL http://hdl.handle.net/2078.1/137070
  1. Pillarisetti Sivaram, Alexander Christopher W., Khanna Ish, Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases, 10.1016/j.drudis.2009.08.002
  2. Gerra Gilberto, Zaimovic Amir, Gerra Maria, Ciccocioppo Roberto, Cippitelli Andrea, Serpelloni Giovanni, Somaini Lorenzo, Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists, 10.2174/157488910789753521
  3. Muccioli Giulio G., Endocannabinoid biosynthesis and inactivation, from simple to complex, 10.1016/j.drudis.2010.03.007
  4. Vandevoorde Séverine, Lambert Didier M., The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out, 10.1002/cbdv.200790156
  5. Vandevoorde Severine, Overview of the Chemical Families of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors, 10.2174/156802608783498005
  6. Seierstad Mark, Breitenbucher J. Guy, Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors, 10.1021/jm800311k
  7. Bertrand T., Augé F., Houtmann J., Rak A., Vallée F., Mikol V., Berne P.F., Michot N., Cheuret D., Hoornaert C., Mathieu M., Structural Basis for Human Monoglyceride Lipase Inhibition, 10.1016/j.jmb.2009.11.060
  8. Feledziak Marion, M. Lambert Didier, Marchand-Brynaert Jacqueline, G. Muccioli Giulio, Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoids Activity by Preventing their Hydrolysis, 10.2174/157488912798842223
  9. Bisogno Tiziana, Maccarrone Mauro, Latest advances in the discovery of fatty acid amide hydrolase inhibitors, 10.1517/17460441.2013.780021
  10. K. Khanna Ish, W. Alexander Christopher, Fatty Acid Amide Hydrolase Inhibitors – Progress and Potential, 10.2174/187152711796234989
  11. Bracey M. H., Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling, 10.1126/science.1076535
  12. McKinney Michele K., Cravatt Benjamin F., STRUCTURE AND FUNCTION OF FATTY ACID AMIDE HYDROLASE, 10.1146/annurev.biochem.74.082803.133450
  13. Labar Geoffray, Michaux Catherine, Fatty Acid Amide Hydrolase: From Characterization to Therapeutics, 10.1002/cbdv.200790157
  14. Mileni M., Johnson D. S., Wang Z., Everdeen D. S., Liimatta M., Pabst B., Bhattacharya K., Nugent R. A., Kamtekar S., Cravatt B. F., Ahn K., Stevens R. C., Structure-guided inhibitor design for human FAAH by interspecies active site conversion, 10.1073/pnas.0806121105
  15. Mileni Mauro, Garfunkle Joie, DeMartino Jessica K., Cravatt Benjamin F., Boger Dale L., Stevens Raymond C., Binding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal Structures, 10.1021/ja902694n
  16. Mileni Mauro, Garfunkle Joie, Ezzili Cyrine, Kimball F. Scott, Cravatt Benjamin F., Stevens Raymond C., Boger Dale L., X-ray Crystallographic Analysis of α-Ketoheterocycle Inhibitors Bound to a Humanized Variant of Fatty Acid Amide Hydrolase, 10.1021/jm9012196
  17. Mileni Mauro, Kamtekar Satwik, Wood David C., Benson Timothy E., Cravatt Benjamin F., Stevens Raymond C., Crystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme Inactivation, 10.1016/j.jmb.2010.05.034
  18. Labar Geoffray, Bauvois Cédric, Borel Franck, Ferrer Jean-Luc, Wouters Johan, Lambert Didier M., Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling, 10.1002/cbic.200900621
  19. Ortar Giorgio, Bisogno Tiziana, Ligresti Alessia, Morera Enrico, Nalli Marianna, Di Marzo Vincenzo, Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism, 10.1021/jm800978m
  20. Bisogno Tiziana, Ortar Giorgio, Petrosino Stefania, Morera Enrico, Palazzo Enza, Nalli Marianna, Maione Sabatino, Di Marzo Vincenzo, Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo, 10.1016/j.bbalip.2008.10.007
  21. Urbach Allan, Muccioli Giulio G., Stern Eric, Lambert Didier M., Marchand-Brynaert Jacqueline, 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors, 10.1016/j.bmcl.2008.05.081
  22. Böttcher Thomas, Sieber Stephan A., β-Lactones as Privileged Structures for the Active-Site Labeling of Versatile Bacterial Enzyme Classes, 10.1002/anie.200705768
  23. Gérard Stéphane, Nollet Gaëtan, Vande Put Jennifer, Marchand-Brynaert Jacqueline, 1-Alkoxycarbonyl-3-halogenoazetidin-2-ones as elastase (PPE) inhibitors, 10.1016/s0968-0896(02)00304-8
  24. Gérard Stéphane, Galleni Moreno, Dive Georges, Marchand-Brynaert Jacqueline, Synthesis and evaluation of N1/C4-substituted β-lactams as PPE and HLE inhibitors, 10.1016/j.bmc.2003.10.009
  25. Gerona-Navarro Guillermo, Pérez de Vega Ma Jesús, Garcı́a-López Ma Teresa, Andrei Graciela, Snoeck Robert, Balzarini Jan, De Clercq Erik, González-Muñiz Rosario, Synthesis and anti-HCMV activity of 1-acyl-β-lactams and 1-acylazetidines derived from phenylalanine, 10.1016/j.bmcl.2004.02.010
  26. Gerona-Navarro Guillermo, Pérez de Vega M. Jesús, García-López M. Teresa, Andrei Graciela, Snoeck Robert, De Clercq Erik, Balzarini Jan, González-Muñiz Rosario, From 1-Acyl-β-lactam Human Cytomegalovirus Protease Inhibitors to 1-Benzyloxycarbonylazetidines with Improved Antiviral Activity. A Straightforward Approach To Convert Covalent to Noncovalent Inhibitors, 10.1021/jm0492812
  27. Marchand-Brynaert J., Brulé C., Penicillins, Comprehensive Heterocyclic Chemistry III (2008) ISBN:9780080449920 p.173-237, 10.1016/b978-008044992-0.00203-0
  28. Feledziak Marion, Michaux Catherine, Urbach Allan, Labar Geoffray, Muccioli Giulio G., Lambert Didier M., Marchand-Brynaert Jacqueline, β-Lactams Derived from a Carbapenem Chiron Are Selective Inhibitors of Human Fatty Acid Amide Hydrolase versus Human Monoacylglycerol Lipase, 10.1021/jm9008532
  29. Berks Andrew H., Preparations of two pivotal intermediates for the synthesis of 1-β-methyl carbapenem antibiotics, 10.1016/0040-4020(95)00842-x
  30. Urbach Allan, Dive Georges, Marchand-Brynaert Jacqueline, Novel Large-Ring 1,3-Bridged 2-Azetidinones as Potential Inhibitors of Penicillin-Binding Proteins, 10.1002/ejoc.200801193
  31. Salzmann Thomas N., Ratcliffe R. W., Christensen B. G., Bouffard F. A., A stereocontrolled synthesis of (+)-thienamycin, 10.1021/ja00539a040
  32. Baldwin Jack E., Adlington Robert M., Gollins David W., Schofield Christopher J., Stereospecific synthesis of dealanylalahopcin, 10.1016/s0040-4020(01)85592-7
  33. Jones Gareth, Willett Peter, Glen Robert C, Leach Andrew R, Taylor Robin, Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen, 10.1006/jmbi.1996.0897
  34. De Lano WL, The PyMOL molecular graphics system, 0.99 (2002)
  35. Gérard Stéphane, Marchand-Brynaert Jacqueline, Protecting group migration in the chemistry of 1-t-butyldimethylsilyl-4-hydroxymethyl-2-azetidinone, 10.1016/s0040-4039(03)01525-9
  36. Feledziak Marion, Muccioli Giulio G., Lambert Didier M., Marchand-Brynaert Jacqueline, SAR and LC/MS Studies of β-Lactamic Inhibitors of Human Fatty Acid Amide Hydrolase (hFAAH): Evidence of a Nonhydrolytic Process, 10.1021/jm200723m
  37. Feledziak Marion, Michaux Catherine, Lambert Didier M., Marchand-Brynaert Jacqueline, An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH), 10.1016/j.ejmech.2012.11.035
  38. Klein Scott I., Molino Bruce F., Czekaj Mark, Gardner Charles J., Chu Valeria, Brown Karen, Sabatino Ralph D., Bostwick Jeffrey S., Kasiewski Charles, Bentley Ross, Windisch Vincent, Perrone Mark, Dunwiddie Christopher T., Leadley Robert J., Design of a New Class of Orally Active Fibrinogen Receptor Antagonists, 10.1021/jm9801096
  39. Menghin Sonja, Pertz Heinz H., Kramer Kai, Seifert Roland, Schunack Walter, Elz Sigurd, Nα-Imidazolylalkyl and Pyridylalkyl Derivatives of Histaprodifen:  Synthesis and in Vitro Evaluation of Highly Potent Histamine H1-Receptor Agonists, 10.1021/jm0309147
  40. Gérard Stéphane, Dive Georges, Clamot Brigitte, Touillaux Roland, Marchand-Brynaert Jacqueline, Synthesis, hydrolysis, biochemical and theoretical evaluation of 1,4-bis(alkoxycarbonyl)azetidin-2-ones as potential elastase inhibitors, 10.1016/s0040-4020(02)00112-6
  41. Labar G., Vliet F. V., Wouters J., Lambert D. M., A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison, 10.1007/s00726-007-0540-1
  42. Labar Geoffray, Bauvois Cédric, Muccioli Giulio G., Wouters Johan, Lambert Didier M., Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2-Arachidonoylglycerol Signaling, 10.1002/cbic.200700139
  43. Mileni Mauro, Garfunkle Joie, Ezzili Cyrine, Cravatt Benjamin F., Stevens Raymond C., Boger Dale L., Fluoride-Mediated Capture of a Noncovalent Bound State of a Reversible Covalent Enzyme Inhibitor: X-ray Crystallographic Analysis of an Exceptionally Potent α-Ketoheterocycle Inhibitor of Fatty Acid Amide Hydrolase, 10.1021/ja110877y
  44. Verdonk Marcel L., Chessari Gianni, Cole Jason C., Hartshorn Michael J., Murray Christopher W., Nissink J. Willem M., Taylor Richard D., Taylor Robin, Modeling Water Molecules in Protein−Ligand Docking Using GOLD, 10.1021/jm050543p
  45. Huang WenJuan, Gherib Rami, Gauld James W., An Active Site Water Broadens Substrate Specificity inS-Ribosylhomocysteinase (LuxS): A Docking, MD, and QM/MM Study, 10.1021/jp3049907
  46. Yoshikawa Yasushi, Kobayashi Kazuya, Oishi Shinya, Fujii Nobutaka, Furuya Toshio, Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4–FC131 interactions, 10.1016/j.bmcl.2012.01.134
  47. Otrubova Katerina, Boger Dale L., α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH), 10.1021/cn2001206
  48. Estiarte M. Angels, Johnson Russell J., Kaub Carl J., Gowlugari Sumithra, O'Mahony Donogh J. R., Nguyen Margaret T., Emerling Daniel E., Kelly Michael G., Kincaid John, Vincent Fabien, Duncton Matthew A. J., 2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH), 10.1039/c2md00307d
  49. Tian Gaochao, Paschetto Kathy A., Gharahdaghi Farzin, Gordon Euan, Wilkins Dee E., Luo Xincai, Scott Clay W., Mechanism of Inhibition of Fatty Acid Amide Hydrolase by Sulfonamide-Containing Benzothiazoles: Long Residence Time Derived from Increased Kinetic Barrier and Not Exclusively from Thermodynamic Potency, 10.1021/bi200552p
  50. Min X., Thibault S. T., Porter A. C., Gustin D. J., Carlson T. J., Xu H., Lindstrom M., Xu G., Uyeda C., Ma Z., Li Y., Kayser F., Walker N. P. C., Wang Z., Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH), 10.1073/pnas.1016167108
  51. Gowlugari Sumithra, DeFalco Jeff, Nguyen Margaret T., Kaub Carl, Chi Candace, Duncton Matthew A. J., Emerling Daniel E., Kelly Michael G., Kincaid John, Vincent Fabien, Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH), 10.1039/c2md20146a
  52. Caprioli A., Coccurello R., Rapino C., Di Serio S., Di Tommaso M., Vertechy M., Vacca V., Battista N., Pavone F., Maccarrone M., Borsini F., The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models, 10.1124/jpet.111.191403
  53. Ezzili Cyrine, Mileni Mauro, McGlinchey Nicholas, Long Jonathan Z., Kinsey Steven G., Hochstatter Dustin G., Stevens Raymond C., Lichtman Aron H., Cravatt Benjamin F., Bilsky Edward J., Boger Dale L., Reversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting Analgesics, 10.1021/jm101597x
  54. Swinney David C., Anthony Jason, How were new medicines discovered?, 10.1038/nrd3480
  55. Kumar Kamal, Waldmann Herbert, Synthesis of Natural Product Inspired Compound Collections, 10.1002/anie.200803437